These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 3080968

  • 21. Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I.
    Mäenpää J, Kangas L, Grönroos M.
    Obstet Gynecol; 1985 Nov; 66(5):708-13. PubMed ID: 3932908
    [Abstract] [Full Text] [Related]

  • 22. [In vitro chemosensitivity of various human tumors evaluated by the succinate dehydrogenase inhibition (SDI) test (2)].
    Anai H, Maehara Y, Kusumoto H, Masuda H, Miyamoto K, Fukuchi K, Tamada R, Sugimachi K.
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2544-8. PubMed ID: 3740857
    [Abstract] [Full Text] [Related]

  • 23. [Chemosensitivity test for bladder cancer in a nude-mice experimental system].
    Yamauchi T, Okada K, Yoshida O, Kawai T.
    Hinyokika Kiyo; 1986 Dec; 32(12):1949-58. PubMed ID: 3825832
    [Abstract] [Full Text] [Related]

  • 24. Overexpression of p27 protein in human breast cancer correlates with in vitro resistance to doxorubicin and mitomycin C.
    Yang Q, Sakurai T, Yoshimura G, Takashi Y, Suzuma T, Tamaki T, Umemura T, Nakamura Y, Nakamura M, Utsunomiya H, Mori I, Kakudo K.
    Anticancer Res; 2000 Dec; 20(6B):4319-22. PubMed ID: 11205265
    [Abstract] [Full Text] [Related]

  • 25. Drug resistance in chemotherapy for breast cancer.
    Saeki T, Tsuruo T, Sato W, Nishikawsa K.
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():84-9. PubMed ID: 16273361
    [Abstract] [Full Text] [Related]

  • 26. [Anticancer drug sensitivity tested by tumor stem cell assay].
    Hiraki S, Ohnoshi T, Miyai M, Numata T, Kishimoto N, Miyamoto H, Kimura I.
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1139-45. PubMed ID: 6471420
    [Abstract] [Full Text] [Related]

  • 27. [Chemosensitivity testing for human ovarian cancer on in vitro colony assay].
    Inoue K.
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1146-51. PubMed ID: 6471421
    [Abstract] [Full Text] [Related]

  • 28. [Update of human tumor clonogenic assay in carcinoma of the lung].
    Kanzawa F.
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1552-9. PubMed ID: 2992395
    [Abstract] [Full Text] [Related]

  • 29. Anticancer chemosensitivity profiles of human breast cancer cells assessed by in vitro DNA synthesis inhibition assay.
    Nio Y, Tamura K, Kan N, Inamoto T, Ohgaki K, Kodama H.
    Anticancer Res; 2000 Aug; 20(2B):1237-44. PubMed ID: 10810427
    [Abstract] [Full Text] [Related]

  • 30. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
    Federico M, Alberts DS, Garcia DJ, Emerson J, Fanta P, Liu R, Salmon SE.
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
    [Abstract] [Full Text] [Related]

  • 31. Pharmacologic validation of human tumor clonogenic assays based on pleiotropic drug resistance: implications for individualized chemotherapy and new drug screening programs.
    Parchment RE, Soleimanpour K, Petrose S, Murphy MJ.
    Int J Cell Cloning; 1992 Nov; 10(6):359-68. PubMed ID: 1334113
    [Abstract] [Full Text] [Related]

  • 32. [Chemosensitivity test for 170 human breast carcinoma samples].
    He Z, Yuan J, Chen Z, Liu S, Shen Z, Fei H.
    Hunan Yi Ke Da Xue Xue Bao; 1998 Nov; 23(6):531-4. PubMed ID: 10806759
    [Abstract] [Full Text] [Related]

  • 33. Mitomycin C and 5-fluorouracil as second choice treatment in advanced breast cancer patients.
    Ardizzoni A, Pronzato P, Conte PF, Rosso R.
    Chemioterapia; 1984 Apr; 3(2):83-5. PubMed ID: 6442624
    [Abstract] [Full Text] [Related]

  • 34. [Sensitivity test of anticancer agents by subrenal capsule assay (SRC assay). II--Determination of tumor sensitivity by percentage inhibition of DNA protein].
    Nishiyama M, Noso Y, Yamaguchi M, Hirabayashi N, Toge T, Niimoto M, Hattori T.
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):275-9. PubMed ID: 3080963
    [Abstract] [Full Text] [Related]

  • 35. [Chemosensitivity of MGc 80-3 human gastric adenocarcinoma cells and its clinical significance].
    Li XT.
    Zhonghua Zhong Liu Za Zhi; 1989 Sep; 11(5):332-4. PubMed ID: 2559835
    [Abstract] [Full Text] [Related]

  • 36. [Comparative study of chemosensitivity tests of human urogenital tumors between a clonogenic assay and a novel dye exclusion test].
    Gohji K, Okada Y, Hamami G, Kamidono S, Ishigami J, Murao S, Aogauchi R, Maeda S, Sugiyama T.
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1294-300. PubMed ID: 2408580
    [Abstract] [Full Text] [Related]

  • 37. [In vitro chemosensitivity test for testicular cancer using a human tumor stem cell assay].
    Yamamoto N, Matsuyama H, Shinohara Y, Shimizu K, Sakatoku J.
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec 20; 20(10):2229-35. PubMed ID: 2420907
    [No Abstract] [Full Text] [Related]

  • 38. A novel assay to assess the effectiveness of antiangiogenic drugs in human breast cancer.
    Lyons JM, Anthony CT, Thomson JL, Woltering EA.
    Ann Surg Oncol; 2008 Dec 20; 15(12):3407-14. PubMed ID: 18795370
    [Abstract] [Full Text] [Related]

  • 39. Clinical applications of the histoculture drug response assay.
    Furukawa T, Kubota T, Hoffman RM.
    Clin Cancer Res; 1995 Mar 20; 1(3):305-11. PubMed ID: 9815986
    [Abstract] [Full Text] [Related]

  • 40. Neoadjuvant chemotherapy for breast cancer determined by chemosensitivity assay achieves better tumor response.
    Lau GI, Loo WT, Chow LW.
    Biomed Pharmacother; 2007 Oct 20; 61(9):562-5. PubMed ID: 17913448
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.